And here's the exciting part: theres a simple, inexpensive solution beyond stop the statin or start a GLP-1 . Well build to that
Well, if we eat a lot of animal products, we may instead be selecting for animal product-digesting bacteria, and it appears some of those waste products, like the trimethylamine, may be harmful
This theoretical Cagrilintide vs Retatrutide combination is generating significant interest among the research community
Among 169,649 patients with MASLD, GLP-1 receptor agonist initiation was linked to significantly lower probability of incident cirrhosis [adjusted hazard ratio (aHR): 0.86, 95%CI: 0.80-0.93], hepatic decompensation (aHR: 0.77, 95%CI: 0.65-0.90), and hepatocellular carcinoma (HCC) (aHR: 0.79, 95%CI: 0.68-0.92) over a median follow-up of 3.5 years compared to non-users